secwatch.observer — SEC 8-K summary
======================================

Issuer:     AETHLON MEDICAL INC (AEMD)
CIK:        0000882291
Form:       8-K
Filed at:   2026-07-07T23:07:31+00:00
Accession:  0001683168-26-005338
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aethlon Medical raises $4.0M in follow-on offering priced at $0.71/unit
-----------------------------------------------------------------------

- Gross proceeds of ~$4.0M from sale of common stock, pre-funded warrants, and warrants; net proceeds ~$3.335M.
- Offering includes 5.63M common warrants exercisable at $0.71 per share, subject to stockholder approval.
- Maxim Group acted as sole placement agent; received 6.25% cash fee and 225,320 placement agent warrants.
- Proceeds to be used for working capital, R&D, clinical trials, and potential acquisitions.
- Lock-up agreements for officers and directors for 90 days; company restricted from issuing securities for 90 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/882291/000168316826005338/0001683168-26-005338-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/882291/000168316826005338/aethlon_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-26-005338

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer